TyTRATE: A Patient Registry to Observe the Real-World Dosing and
Titration of Tyvaso
Sponsor: United Therapeutics
PI: Steve Domsky, MD
CRC: Nancy Britton, RN - 484.476.8578
To characterize the observed dosing and titration of Tyvaso in patients
newly initiating therapy for Pulmonary Arterial Hypertension. Patients
newly initiated on Tyvaso and willing to be followed for 6 months.
For additional information on cardiovascular clinical
trials, please call Ann Marie Chikowski, BSN, RN, CCRC, Clinical
Research Manager at 484.476.3030.
For more information, call 1.866.CALL.MLH.